Lung Function

WASHINGTON — Annual lung function decline rates were lower in individuals who had high adherence to a plant-centered diet, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.

As wildfires rage in Canada, raising new air quality concerns in the eastern United States, Healio has compiled a list of recent articles detailing the impacts of wildfires on allergy, asthma and beyond.

WASHINGTON — Initial measures of lung function were reduced in patients with COPD who lived in socially vulnerable communities, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — Children with asthma who lived within 500 meters of a fast-food restaurant had smaller changes in lung function during an intervention, according to data presented at the American Thoracic Society International Conference.

WASHINGTON — Patients with severe emphysema had improved lung function at 5 years after receiving treatment with a support expiration valve system, according to research presented at the American Thoracic Society International Conference.

WASHINGTON — Oscillometry was a successful objective measure of lung function among children presenting to the ED with acute asthma, according to data presented at the American Thoracic Society International Conference.

WASHINGTON — Children with asthma did not see any significant differences in lung function or symptom control up to 18 months after acute COVID-19, according to data presented at the American Thoracic Society International Conference.

WASHINGTON — Women with asthma had worse disease control and higher risks for exacerbations compared with men, according to data presented at the American Thoracic Society International Conference.

WASHINGTON — Over 12 or 24 weeks, patients with COPD receiving ensifentrine showed improved measures of lung function, quality of life and exacerbation rate, according to an American Thoracic Society International Conference presentation.